Cargando…
Fibrosis in Autoimmune and Cholestatic Liver Disease
Autoimmune and cholestatic liver disease account for a significant part of end-stage liver disease and are leading indications for liver transplantation. Especially cholestatic liver diseases (primary biliary cirrhosis and primary sclerosing cholangitis) appear to be different from other chronic liv...
Autores principales: | Penz-Österreicher, Melitta, Österreicher, Christoph H., Trauner, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134112/ https://www.ncbi.nlm.nih.gov/pubmed/21497742 http://dx.doi.org/10.1016/j.bpg.2011.02.001 |
Ejemplares similares
-
Novel therapeutic targets for cholestatic and fatty liver disease
por: Trauner, Michael, et al.
Publicado: (2022) -
Nuclear Receptors as Drug Targets in Cholestatic Liver Diseases
por: Halilbasic, Emina, et al.
Publicado: (2013) -
Single-sex infection with female Schistosoma mansoni cercariae mitigates hepatic fibrosis after secondary infection
por: Koslowski, Nicole, et al.
Publicado: (2017) -
Osteosarcopenia in autoimmune cholestatic liver diseases: Causes, management, and challenges
por: Pugliese, Nicola, et al.
Publicado: (2022) -
24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis
por: Sombetzki, Martina, et al.
Publicado: (2015)